SPECTRALYS BIOTECH
0712.775.992 · rovalta.com · 25/09/2026
SPECTRALYS BIOTECH
Financial year 2025 · Closed on 31/12/2025
Overview
Identity
Source · BCE/KBOSPECTRALYS BIOTECH is a Private limited company incorporated in 2018. Its main activity is: Research and experimental development on natural sciences and engineering. Its registered office is in Charleroi.
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0712.775.992
- Incorporation
- 31/10/2018
- Legal form
- Private limited company
- Registered office
- Rue Clément Ader 10
6041 Charleroi · WallonieSee on map - Contributed capital
- 18 600,00 €
- Latest accounts
- 31/12/2025
Joint committees (1)
- 207
Financials
Source · NBB, 7 filingsTrend over 5 financial years
| 2025 | 2024 | 2023 | 2022 | 2021 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Gross margin | 143,7 k € | +38.8% | 103,5 k € | +7.2% | 96,6 k € | -10.2% | 107,5 k € | -41.1% | 182,5 k € |
| EBITDA | 70,3 k € | +106% | 34,2 k € | +17.1% | 29,2 k € | -38.0% | 47,1 k € | -63.1% | 127,6 k € |
| Operating result | 57,7 k € | +191% | 19,8 k € | -29.1% | 28 k € | -28.8% | 39,3 k € | -67.2% | 119,8 k € |
| Net result | 58,2 k € | +98.1% | 29,4 k € | +36.5% | 21,5 k € | -27.9% | 29,8 k € | -69.3% | 97,3 k € |
| Balance sheet | |||||||||
| Equity | 313 k € | +23.4% | 253,8 k € | +26.9% | 200 k € | -10.5% | 223,5 k € | -23.9% | 293,7 k € |
| Total assets | 444,7 k € | +45.7% | 305,2 k € | +10.2% | 276,9 k € | -24.9% | 368,8 k € | +6.0% | 347,8 k € |
| Cash | 146,8 k € | +44.3% | 101,7 k € | -19.3% | 126,1 k € | -44.6% | 227,4 k € | -14.1% | 264,9 k € |
| Debts | 131,7 k € | +156% | 51,4 k € | -33.0% | 76,8 k € | -47.2% | 145,3 k € | +169% | 54,1 k € |
Valuation
Indicative valuation
As an indication, this company is worth
Board of directors
Source · NBB, accounts to 31/12/20251 active
Active mandates
Other companies at this address
Rue Clément Ader 10 6041 Charleroi| Company | CBE no. |
|---|---|
2 Bridge WL● Active | 1003.906.745 |
3D Fibroscreen● Active | 1022.772.354 |
AdipoPharma Belgique● Active | 1008.146.338 |
ATRYON BELGIUM● Active | 0751.698.530 |
| 0479.250.670 | |
ConvEyXo● Active | 0725.874.259 |
CONVEYXO GROUP● Active | 1016.957.797 |
ELKEDONIA BELGIUM● Active | 1021.635.177 |
ENDO TOOLS THERAPEUTICS● Active | 0807.570.233 |
Enodia Therapeutics Belgium● Active | 1039.324.811 |
EU BIOTECH CAMPUS● Active | 0776.668.706 |
Exo-Harvest● Active | 0803.425.264 |
Hemastatx● Active | 1019.406.058 |
Immunofusion● Active | 0804.563.629 |
ImmunXperts● Active | 0552.755.587 |
INCHINN THERAPEUTICS● Active | 0799.914.755 |
INSTAR BELGIQUE● Active | 1039.395.085 |
KOKUMA● Active | 0799.078.377 |
LYS MEDICAL● Active | 0688.626.061 |
MILEUTIS● Active | 1011.400.984 |
Financials
Full financial information
Source · NBB| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Type of account | Micro model | Micro model | Micro model | Micro model | Micro model | Micro model |
| Start of the financial year | 01/01/2025 | 01/01/2024 | 01/01/2023 | 01/01/2022 | 01/01/2021 | 01/01/2020 |
| Closing of the financial year | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 | 31/12/2021 | 31/12/2020 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 04/06/2026 | 06/06/2025 | 04/06/2024 | 13/06/2023 | 13/06/2022 | 18/06/2021 |
| General meeting | 01/06/2026 | 02/06/2025 | 03/06/2024 | 05/06/2023 | 07/06/2022 | 07/06/2021 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for 7 daysAnnual accounts filings
Source · NBB, 7 filings| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Micro model | 31/12/2025 | 01/06/2026 | 04/06/2026 | French | |
| Micro model | 31/12/2024 | 02/06/2025 | 06/06/2025 | French | |
| Micro model | 31/12/2023 | 03/06/2024 | 04/06/2024 | French | |
| Micro model | 31/12/2022 | 05/06/2023 | 13/06/2023 | French | |
| Micro model | 31/12/2021 | 07/06/2022 | 13/06/2022 | French | |
| Micro model | 31/12/2020 | 07/06/2021 | 18/06/2021 | French | |
| Micro model | 31/12/2019 | 02/06/2020 | 05/06/2020 | French |
Valuation
Indicative valuation
As an indication, this company is worth
between 500 k€ and 1 M€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 31/12/20251 active
Active mandates
Ownership and network
Looking for more information about this company?
Try for 7 daysPublications
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2025Annual accounts 202558,2 k €↑
- 2024Annual accounts 202429,4 k €↑
- 2023Annual accounts 202321,5 k €↓
- 2022Annual accounts 202229,8 k €↓
- 2021Annual accounts 202197,3 k €
- 31/10/2018IncorporationPrivate limited company